Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
618,504
-
Shares change
-
-24,496
-
Total reported value, excl. options
-
$109,495,602
-
Value change
-
-$4,592,717
-
Number of buys
-
26
-
Number of sells
-
-37
-
Price
-
$176.98
Significant Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q3 2023
133 filings reported holding IHE - ISHARES TR - U.S. PHARMA ETF as of Q3 2023.
ISHARES TR - U.S. PHARMA ETF (IHE) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 618,504 shares
.
Largest 10 shareholders include ENVESTNET ASSET MANAGEMENT INC (64,031 shares), RAYMOND JAMES & ASSOCIATES (56,974 shares), MORGAN STANLEY (55,902 shares), Royal Bank of Canada (37,167 shares), BROWN ADVISORY INC (32,334 shares), BANK OF AMERICA CORP /DE/ (30,600 shares), LPL Financial LLC (24,123 shares), GOLDMAN SACHS GROUP INC (23,586 shares), WELLS FARGO & COMPANY/MN (22,146 shares), and Fisher Asset Management, LLC (21,317 shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.